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Effects of a Walking Aid in COPD
Patients Receiving Oxygen Therapy*
Ernesto Crisafulli, MD; Stefania Costi, RT; Francesco De Blasio, MD, FCCP;
Gianluca Biscione, MD, FCCP; Francesca Americi, RT; Sergio Penza, RT;
Erika Eutropio, RT; Franco Pasqua, MD, FCCP;
Leonardo M. Fabbri, MD, FCCP; and Enrico M. Clini, MD, FCCP
Study objectives: To elucidate whether a simple walking aid may improve physical performance
in COPD patients with chronic respiratory insufficiency who usually carry their own heavy oxygen
canister.
Design: Randomized crossover trial.
Setting: Physiopathology laboratory of three rehabilitation centers.
Patients and interventions: We studied 60 stable COPD patients (mean age, 70.6  7.9 years;
FEV1, 44.8  14.3% of predicted [ SD]) with chronic respiratory insufficiency who randomly
performed, on 2 consecutive days, a standardized 6-min walking test using two different
modalities: a full-weight oxygen canister transported using a small wheeled cart and pulled by the
patient (Aid modality) or full-weight oxygen canister carried on the patient’s shoulder (No-Aid
modality).
Measurements and results: The distance walked, peak effort dyspnea, and leg fatigue scores as
primary outcomes, and other cardiorespiratory parameters as secondary outcomes were re-
corded during both tests. A significant difference (p < 0.05) between the two tests occurred for
all the measured outcomes in favor of the Aid modality. Most importantly, significant changes for
distance ( 43 m, p < 0.001), peak effort dyspnea ( 2.0 points, p < 0.001), leg fatigue ( 1.4
points, p < 0.001), as well as for mean and nadir oxygen saturation and heart rate with the Aid
modality (but not with the No-Aid modality) were recorded in the subgroup of patients walking
< 300 m at baseline.
Conclusions: This study suggests that a simple walking aid may be helpful in COPD patients
receiving long-term oxygen therapy, particularly in those with lower residual exercise capacity.
(CHEST 2007; 131:1068–1074)
Key words: exercise; 6-min walking test; symptoms; wheeled cart
Abbreviations: Fio2  fraction of inspired oxygen; HR heart rate; 6MWT 6-min walking test; LTOT long-term
oxygen therapy; Sao2  arterial oxygen saturation
P atients with COPD have reduction in functionalexercise capacity as the disease progresses. In
these patients, dyspnea may become so disabling that
they lead a sedentary lifestyle, which results in
further deconditioning, worsening of symptoms, and
reduced quality of life.1
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It is noteworthy that walking represents a funda-
mental ability to perform several activities of daily
living. Furthermore, pulmonary rehabilitation pro-
grams aim to encourage walking as an important,
useful, and preferred form of exercise for many
patients with COPD.2
Wheeled walking aids are sometimes prescribed
for patients with COPD to improve their functional
exercise capacity.3 Until now, information on the
influence of wheeled walking aids in patients with
COPD was limited because of studies that have used
small sample sizes3–5 or subjects with mild disease.5
More recently, it has been shown that walking with a
rollator (which supports the upper arms) is effective
in improving both physical performance and reduc-
ing dyspnea in severely disabled patients with
COPD.6
In patients with chronic respiratory insufficiency
and preserved walking ability but needing external
oxygen, the use of a heavy portable oxygen canister
(stroller) can produce an immediate limitation of
functional exercise capacity due to its weight and the
increasing respiratory and skeletal muscle load. In-
herent to this, no study has yet investigated which
clinical effects are determined when pulling the
oxygen canister on a wheeled cart during deambula-
tion. This study, therefore, was undertaken to com-
pare walking distance, symptoms, and main physio-
logic parameters during walking with the oxygen
canister carried on the shoulder, or pulled using a
small, wheeled cart in COPD patients receiving
long-term oxygen therapy (LTOT).
Materials and Methods
Patients
Consecutive COPD inpatients who were admitted to a com-
prehensive pulmonary rehabilitation program from January to
December 2005 at the hospital facilities of Villa Pineta (Gaiato-
MO), IRCCS San Raffaele (Velletri-Roma), and Clinic Center
(Napoli) were recruited. The predetermined recruitment of 20
patients per center was finalized.
Eligible patients had to receive LTOT for at least 6 months
before enrollment and be in stable condition with no evidence of
acute exacerbation or change in medication in the previous 4
weeks. The diagnosis of COPD was been made according to the
Global Initiative for Chronic Obstructive Lung Disease stage and
definition.7
All patients were all able to walk without assistance and
perform the 6-min walking test (6MWT) according to the current
recommendations.8 The presence of associated medical condi-
tions that substantially limited exercise tolerance and perfor-
mance (ie, symptomatic cardiovascular conditions, advanced os-
teoarthrosis) or malignancies represented study exclusion
criteria.
The selected patients gave their consent to participate in the
study. All trial procedures were conducted according to the
Declaration of Helsinki.
Study Design
A randomized crossover design was used in this trial. Each
patient performed two 6MWTs at the same time on 2 consecutive
days in the first week after hospital admission. The test order was
randomized according to a random-number table on the first day
and then reversed on the second day. In each center, a small
group of three or four trained physiotherapists unaware of the
study purpose directed the tests on both days; both tests in the
same patient were administered by the same physiotherapist.
The study condition consisted of testing the patient while he
pulled a full oxygen canister on the floor using a small, light,
wheeled cart (Aid modality). The control test was conducted by
carrying the same oxygen canister on the patient’s shoulder
(No-Aid modality) [Fig 1]. A similar canister (3.5 kg) was used in
both conditions; a continuous oxygen flow (3 L/min) was similarly
provided to patients during both tests.
Pretest Evaluations
Baseline data included primary demographic and anthropo-
metric variables. Arterial blood was obtained from the radial
artery at rest to obtain Pao2, Paco2, and pH values by means of
an automated analyzer (Model 850; Chiron Diagnostics; Med-
field, MA). Patients breathed spontaneously with transnasal
oxygen at the usual flow able to correct baseline hypoxemia; the
fraction of inspired oxygen (Fio2) was then calculated.
Forced lung volumes (FEV1, FVC) were assessed by means of
a spirometer (Masterscope; Jaeger; Hoechberg, Germany). Pre-
dicted values according to Quanjer et al9 were used.
6MWT
Standardized instructions for 6MWT and encouragement were
provided to patients according to recommended guidelines.8 The
6MWT is a measure widely used in clinical practice to determine
exercise tolerance in COPD patients. In the present study, both
tests were conducted indoors in a corridor (40 m in length, and
3 m in width) similar in both centers, under quiet conditions with
a minimum of distractive stimuli. All subjects performed at least
one practice walk before data collection in order to minimize
learning and practice effects.10 Cardiorespiratory functions were
continuously monitored at rest and during the test by means of a
finger probe pulse oximeter (Pulsox 3; Minolta; Tokyo, Japan).
Figure 1. Experimental setting of the two 6MWTs. Left, A: the
oxygen canister is carried on the patient’s shoulder. Right, B: the
oxygen canister is transported using a small, light, wheeled cart.
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The patient’s perceived peak effort dyspnea and leg fatigue were
measured by pointing to a number or phrase on a 10-point
modified Borg scale11 set in large type on a sheet. This assess-
ment was made during the last minute of walking. Furthermore,
the walking speed (kilometers per hour) was calculated by
recording the distance walked in each minute.
Outcomes
Primary: Exercise tolerance (as assessed by means of the timed
walking distance during 6MWT), peak effort dyspnea, and leg
fatigue were the primary outcomes of the study.
Secondary: Mean arterial oxygen saturation (Sao2) and heart
rate (HR) values at rest and during the walking period, Sao2
mean change, and Sao2 nadir represented the secondary study
outcomes.
Statistical Analysis
Analysis of study variables was performed using a statistical
software package (SPSS, version 8.0; SPSS; Chicago, IL). All
study data were analyzed in the total sample and in two sub-
groups of patients according to their ability to walk ( 300 m or
 300 m on baseline standard 6MWT), as previously suggest-
ed.3,6,12
Results are expressed as mean with SD for descriptive data or
mean with SE for all other measures. Differences of the outcome
measures in the No-Aid and Aid modalities were analyzed using
a two-tailed Student t test. The Wilcoxon test for nonparametric
variables was used to assess the difference in peak effort dyspnea
and leg fatigue. For all statistical analyses, an  error  5% was
considered significant.
Results
Sample Characteristics
Sixty COPD patients (mean age, 70.6 years) were
included in the study. General characteristics of the
study sample are shown in Table 1.
On average, patients had normal body mass index
values and normal resting arterial oxygenation under
correction with appropriate external Fio2. Thirty-
seven patients walked  300 m during standard
6MWT (No-Aid modality).
6MWT Distance
Table 2 shows the results of the two walking
session modalities in the total sample. Overall, dis-
tance walked and symptoms (primary outcomes)
significantly improved when the patients pulled the
oxygen canister using the wheeled cart (Aid modal-
ity). Moreover, cardiorespiratory parameters re-
corded during the walking activity (secondary out-
comes) were significantly better with the Aid
modality (Table 2), indicating this to be a less
stressful condition. In particular, a less pronounced
change of any Sao2 parameters was recorded during
the Aid modality.
The same improvements in both primary and
secondary outcomes due to the Aid modality were
even more striking in the subgroup of patients who
had a walking distance  300 m, whereas no signif-
icant differences were observed in the subgroup of
patients who walked  300 m (Table 3). 6MWT
walking speed (kilometers per hour) for the Aid and
No-Aid modalities is shown in Figure 2. In both
modalities, there was a progressive decline in walk-
ing speed during the test. However, walking speed
significantly and consistently improved with the Aid
modality in the total sample and in the subgroup of
less performing patients in particular (Fig 2).
Table 1—General Characteristics of the Study Sample*
Characteristics
Total Sample
(n  60)
Patients Who Walked  300 m
(n  37)
Patients Who Walked  300 m
(n  23)
Sex
Male 36 22 14
Female 24 15 9
Age, yr 70 (8) 69 (8) 72 (7)
Weight, kg 74 (17) 76 (18) 71 (16)
Height, cm 164 (2) 165 (1) 162 (1)
Body mass index, kg/m2 27.7 (7.0) 28.3 (7.8) 26.8 (5.6)
Supplemental oxygen required (Fio2), % 25.7 (4.0) 26.0 (4.8) 25.1 (2.5)
FVC
L 2.1 (0.6) 2.1 (0.7) 1.9 (0.5)
% predicted 65.5 (15.2) 63.6 (15.0) 68.5 (15.2)
FEV1
L 0.9 (0.3) 1.0 (0.3) 0.9 (0.3)
% predicted 44.8 (14.3) 46.3 (15.7) 42.3 (11.7)
FEV1/FCV, % 49.4 (14.7) 51.2 (16.9) 46.5 (10.1)
Pao2, mm Hg 66.4 (8.9) 66.3 (8.2) 66.6 (10.3)
Paco2, mm Hg 48.1 (10.8) 46.3 (9.8) 50.8 (12.0)
Pao2/Fio2 262 (43) 261 (44) 266 (39)
pH 7.41 (0.05) 7.40 (0.05) 7.41 (0.03)
*Data are presented as No. or mean (SD).
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Discussion
This study shows that walking with a wheeled cart
is able to improve distance, symptoms, and cardio-
pulmonary parameters in COPD patients receiving
LTOT. These results are of particular relevance
among the subgroup of patients who are more
disabled.
Although there are still not sufficient data in the
literature regarding activities in patients receiving
LTOT, a randomized controlled trial13 has shown
that outdoor walking distance improves in patients
receiving portable oxygen with respect to those
receiving oxygen concentrators only. Nevertheless,
only 60% of patients provided with a portable oxygen
device use it outdoors and for walking.13
One of the possible explanations for this finding
could be the weight of the device bearing on the
patient’s shoulder during outdoor use. Additionally,
the load of a portable device might also negatively
influence the patient’s walking speed, which in turn
may have practical consequences in everyday life.
Indeed, walking speed frequently represents a prac-
tical issue in elderly pedestrians who are at risk of
being struck by cars when crossing the street14; in
that study, patients walking below the threshold limit
of 300 m in 6MWT are those performing at a speed
that exposes them to the above-mentioned risk;
therefore, this subgroup of disabled patients should
be of particular interest when strategies for any
functional and/or practical improvements are consid-
ered (as in the present study).
Previous trials have already shown that the use of
a rollator as a wheeled walking aid during standard
6MWT is associated with a significant improvement
in physical performance, dyspnea,6,15,16 and oxygen-
ation17,18 in patients with COPD. Taking into con-
sideration these data, we then hypothesized that
COPD patients with chronic respiratory insuffi-
Table 3—Outcomes During 6MWT Modalities in Patients With Different Levels of Walking Ability*
Outcomes
Patients Who Walked  300 m Patients Who Walked  300 m
No-Aid Aid p Value Aid No-Aid p Value
Distance, m 213 (7) 256 (8) 0.001 340 (6) 349 (7) 0.147
Distance, % predicted 48 (2) 59 (3) 0.001 79 (4) 80 (3) 0.251
Peak effort dyspnea, Borg score† 6.0 (0.3) 4.0 (0.3) 0.001 5.5 (0.4) 3.8 (0.5) 0.001
Peak leg effort fatigue, Borg score† 5.1 (0.3) 3.7 (0.3) 0.001 5.1 (0.4) 3.4 (0.3) 0.001
HR at rest, beats/min 101 (3) 99 (2) 0.522 95 (3) 96 (2) 0.755
Maximum HR during 6MWT, beats/min 116 (2) 111 (2) 0.013 111 (4) 107 (3) 0.107
Maximum HR, % predicted 77 (1) 74 (1) 0.017 75 (3) 73 (2) 0.093
Peak effort respiratory rate, breaths/min 29 (1) 26 (1) 0.001 26 (1) 23 (1) 0.007
Sao2 at rest, % 95.3 (0.5) 95.5 (0.3) 0.127 94.9 (0.4) 95.4 (0.3) 0.352
Sao2 during 6MWT, % 89.8 (0.4) 91.3 (0.4) 0.001 90.6 (0.5) 91.0 (0.5) 0.307
Arterial oxyhemoglobin saturation during 6MWT, % 5.2 (0.4) 4.1 (0.4) 0.001 4.4 (0.5) 4.3 (0.5) 0.965
Nadir of arterial oxyhemoglobin saturation during
6MWT, %
86.1 (0.9) 87.2 (0.9) 0.030 87.5 (0.8) 87.4 (0.8) 0.940
*Data are presented as mean (SE).
†Differences calculated using a Wilcoxon test.
Table 2—Outcomes During 6MWT Modalities in All Studied Patients*
Outcomes No-Aid Aid p Value
Distance walked, m 262 (9) 291 (8) 0.001
Distance walked, % predicted 60 (2) 67 (2) 0.001
Peak effort dyspnea, Borg score† 5.8 (0.3) 3.9 (0.3) 0.001
Peak effort leg fatigue, Borg score† 5.1 (0.2) 3.6 (0.2) 0.001
HR at rest, beats/min 99 (2) 98 (1) 0.672
Maximum HR during 6MWT, beats/min 114 (2) 109 (2) 0.003
Maximum HR, % predicted 76 (1) 73 (1) 0.003
Peak effort respiratory rate, breaths/min 28 (1) 25 (1) 0.001
Sao2 at rest, % 95.0 (0.3) 95.4 (0.2) 0.084
Sao2 during 6MWT, % 90.1 (0.3) 91.2 (0.3) 0.001
Arterial oxyhemoglobin desaturation during 6MWT, % 4.9 (0.3) 4.2 (0.3) 0.027
Nadir of arterial oxyhemoglobin desaturation during 6MWT, % 86.6 (0.6) 87.3 (0.6) 0.086
*Data are presented as mean (SE).
†Differences calculated using Wilcoxon test.
www.chestjournal.org CHEST / 131 / 4 / APRIL, 2007 1071
Copyright © 2007 by American College of Chest Physicians 
 on April 10, 2007 chestjournals.orgDownloaded from 
ciency who need external oxygen could also benefit
from a specific device to help them to carry the
oxygen canister during a physical test. Although
wheeled walkers offer important advantages over
standard walkers (those without wheels), the effect
of wheeled walkers or of different tool aids on
functional capacity and activities of daily living has
not been studied extensively. To our knowledge, this
study is the first to explore the effects of a different
type of walking aid (wheeled cart) on physical per-
formance.
Basically, our results show that during the timed
walking test, the use of a wheeled cart to carry the
oxygen canister enabled LTOT users to significantly
increase by a mean of approximately 30 m the
distance walked with less dyspnea and leg fatigue,
which is a practical objective to be reached in the
everyday life of these individuals. Although the
minimal change of  54 m in 6MWT has been so far
suggested as the threshold for a clinically significant
improvement after a clinically based intervention, it
should be noted that that change was based on a
different COPD population with an average baseline
distance walked of  350 m.19 Furthermore, this
objective is likely to be reached after a specific and
structured therapeutic intervention involving muscu-
lar activities like comprehensive pulmonary rehabil-
itation.2 Given that our patients walked approxi-
mately 260 m in the No-Aid modality, the change of
 29 m with the Aid modality is likely to be mean-
ingful, especially since all had considerable clinical
improvements in dyspnea and leg muscle fatigue
when walking with the small wheeled cart. As a
matter of fact, the mean distance change as obtained
in our patients was simply achieved by helping them
to move better and to walk with less fatigue.
When looking at the subgroup of subjects with
greater disability (6MWT distance  300 m), the
change in the distance walked was even more strik-
ing (mean gain, 43 m), while symptoms were almost
reduced to the same extent as in the total sample and
in the other subgroup of patients. This fact under-
Figure 2. Walking speed in kilometers per hour (Km/h) during the 6MWT with No-Aid (solid squares)
and Aid (open circles) modalities in the total sample (top, A) and in patients who performed  300 m
(center, B) or  300 m (right, C). *p  0.05.
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lines the significant clinical advantage that even the
more disabled and home-bound patients may reach
by using this walking strategy.
Analysis of walking speed per minute also con-
firmed the Aid modality to be a more advantageous
way to conduct the timed walking test. Indeed, speed
was significantly higher each minute than in the
No-Aid modality in subjects with greater disability
(Fig 2).
The clinical advantages obtained in our study are
likely to be ascribed to the abolished weight and
mechanical load on the patient’s shoulder girdle
during the Aid-modality as compared with the usual
No-Aid condition. Solway and coworkers,6 in their
study on the efficacy of the rollator, have supposed
that the benefits reached were not dependent on the
amount of total weight (including the rollator) ap-
plied to patients but rather on the firm stabilization
of their arms on the walker, thus allowing the
individual’s shoulder girdle muscles to act more
effectively as accessory muscle of respiration.19–23
However, in this study the electromyographic activ-
ity of accessory muscles was not evaluated. The
reduction in dyspnea, as well as improvement in
exercise capacity, has been observed in previous
articles3,4,7,17 in which the effects of a wheeled
walking aid were evaluated.
Overall, walking aids allow the patient to stabilize
his/her arms, enabling arm and shoulder girdle mus-
cles to participate more effectively as accessory
muscles of inspiration, and (eventually) to adopt a
forward-leaning position during walking, which is
thought to improve the mechanical efficiency of the
diaphragm. These mechanisms are two of several
mechanisms that could play a role in the reduction of
the sensation of dyspnea. Pulling a light cart to carry
the oxygen canister also favors stabilization of the
arms during walking. Another factor that might have
contributed to the reduction of dyspnea and in-
creased walking distance is the sense of confidence
and security and equilibrium that the aid offers.
Another, similar study17 in which patients wore a
portable metabolic system was conducted by the
same group of investigators, who confirmed that
aiding walking may result in a more efficient perfor-
mance by incrementing the individual’s ventilatory
capacity and by reducing the oxygen uptake.17 How-
ever, the population in that study was less disabled
(mean, 416 m on 6MWT) than the population
studied in our trial. Although we cannot extrapolate
those conclusions to our study population due to
different patient characteristics and to the use of a
different walking aid, we are confident that these
conclusions may be applied to patients with more
severe disease.
Despite the favorable results, our study presents
some limitations that need to be addressed. First,
our population was selected because of their ability
to perform 6MWT, and this was a prerequisite for
participation in the study. Nonetheless, it is likely
that more disabled patients who are unable to per-
form a standard time test may benefit from this aid in
their everyday activities involving the lower limbs.
Second, since this was not a physiologic study, it is
possible only to speculate that the overall improve-
ment of the cardiopulmonary response during the
Aid modality reflects a true pathophysiologic adap-
tation of the patients to a different stimulus involving
less oxygen uptake and a reduced metabolic response
at the skeletal muscle level. It is noteworthy, how-
ever, that walking speed was steadily maintained
higher during the Aid modality. Thirdly, the favor-
able result that we obtained in COPD patients, and
in the subgroup of more disabled patients in partic-
ular, cannot be automatically translated to LTOT
users with a different underlying diagnosis (ie, pa-
tients with restrictive thoracic diseases).
In conclusion, our study suggests that the use of a
wheeled canister may be helpful in COPD patients
needing external oxygen, particularly in those with a
lower residual exercise capacity. The increase in
walking speed, and the reduction in symptoms and
oxygen desaturation recorded with aid may translate
into a potential physiologic improvement during
exercise involving the lower limbs in the patient’s
everyday life.
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